Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Journey Medical (DERM) Amortization - Intangibles (2024 - 2026)

Journey Medical filings provide 2 years of Amortization - Intangibles readings, the most recent being $1.1 million for Q4 2025.

  • On a quarterly basis, Amortization - Intangibles rose 8.56% to $1.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.3 million, a 24.39% increase, with the full-year FY2025 number at $4.3 million, up 24.36% from a year prior.
  • Amortization - Intangibles hit $1.1 million in Q4 2025 for Journey Medical, roughly flat from $1.1 million in the prior quarter.
  • In the past five years, Amortization - Intangibles ranged from a high of $1.1 million in Q1 2025 to a low of $814000.0 in Q1 2024.